FDA Approves Abbott HPV Test for Molecular PCR Platform
Abbott received FDA approval for its molecular HPV screening solution for its Alinity m family of diagnostic assays.
Read MorePosted by Andy Lundin | Nov 2, 2023 | Cervical (HPV), Molecular Diagnostics |
Abbott received FDA approval for its molecular HPV screening solution for its Alinity m family of diagnostic assays.
Read MorePosted by Andy Lundin | Oct 26, 2023 | Covid 19 |
Researchers developed a novel platform that couples nanopore technology with artificial intelligence for rapid and accurate COVID testing.
Read MorePosted by Andy Lundin | Oct 20, 2023 | Covid 19 |
3EO Health announced the receipt of an FDA emergency use authorization (EUA) for its SARS-CoV-2 molecular test.
Read MorePosted by Andy Lundin | Oct 20, 2023 | Diagnostic Technologies |
WHO updated its Essential Diagnostics List, a register of in vitro diagnostics supporting countries to make national diagnostic choices.
Read MorePosted by Andy Lundin | Oct 18, 2023 | Company News, Flu & Respiratory Infections |
Evidation has been awarded a contract by BARDA to fund the 2023 Influenza-like Illness (ILI) Detect & Protect Studies.
Read More